0.6975
price down icon0.36%   -0.0026
 
loading

Xilio Therapeutics Inc (XLO) 財務データ

損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
期間の長さ 3 か月 3 か月 3 か月 3 か月 3 か月
Revenues
175.90%
8.084
2.93 1.724 2.263 2.357
Operating Expenses
33.78%
22.45
16.78 15.35 17.02 17.06
Benefits Costs and Expenses
100.00%
-
16.20 14.82 - -
Costs And Expenses
38.62%
22.45
16.20 14.82 17.02 17.06
Operating Income/Loss
3.72%
-14.37
-13.85 -13.63 -14.76 -14.70
Nonoperating Income/Loss
352.22%
-1.478
0.586 0.536 0.742 0.779
Income/Loss From Continuing Operations Before Tax
160.94%
8.084
-13.27 -13.09 2.263 2.357
Income/Loss From Continuing Operations After Tax
19.44%
-15.84
-13.27 -13.09 -14.02 -13.93
Net Income/Loss
19.44%
-15.84
-13.27 -13.09 -14.02 -13.93
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
29.11%
96.45
74.70 3.7486 63.47 57.76
Basic Earnings Per Share
11.11%
-0.16
-0.18 -0.18 -0.22 -0.24
Diluted Earnings Per Share
11.11%
-0.16
-0.18 -0.18 -0.22 -0.24
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.50
price up icon 0.68%
$84.18
price down icon 0.59%
$26.57
price up icon 1.09%
$103.92
price down icon 1.04%
$131.38
price up icon 2.34%
biotechnology ONC
$307.47
price down icon 0.36%
大文字化:     |  ボリューム (24 時間):